Stevens-Johnson syndrome induced by gabapentin and cilostazol in diabetic patient co-infected with COVID-19

Coronavirus disease 2019 (COVID-19) has been declared as an emergent pandemic. COVID-19 mainly present with fever and respiratory symptoms. Its severity ranges from asymptomatic infection, mild, moderate, severe to critical degrees which is related the degree of dysregulated inflammatory response systemic inflammation. Stevens-Johnson syndrome (SJS), on other hand a rare, severe, type IV hypersensitivity presenting epithelial destruction skin mucous membranes. This condition also associated proinflammatory state. We report case 73-years-old woman dry cough fever, who recently started treatment cilostazol gabapentin, then followed by redness blistering her lips, trunk, genital subsequently diagnosed SJS.